SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Feb 23, 2016
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Feb. 23, 2016 · CIK: 0001533998 · Accession: 0001144204-16-083883
AI Filing Summary & Sentiment
File numbers found in text: 333-209002
Show Raw Text
CORRESP
1
filename1.htm
February 23, 2016
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
LabStyle Innovations Corp. (CIK: 0001533998)
Registration Statement No. 333-209002 on Form S-1 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules
and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities
Act”), H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC, as representatives of the underwriters, hereby request
acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m.
Eastern Time, February 25, 2016, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities
Act, please be advised that during the period from February 17-23, 2016, we, acting on behalf of the several underwriters, distributed
as many electronic copies of the Preliminary Prospectus, dated February 16, 2016, as appears to be reasonable to secure adequate
distribution of the Preliminary Prospectus.
By:
H.C. WAINWRIGHT & CO., LLC
By:
Joseph Gunnar & Co., LLC
By: /s/ Mark W. Viklund
By: /s/ Eric Lord
Name: Mark W. Viklund
Name: Eric Lord
Title: Chief Executive Officer
Title: Head of Investment Banking/Underwritings